0Y7T Allergan Plc

TIDM0Y7T

RNS Number : 3535M

JPMorgan Securities Plc

08 May 2020

Ap24

   FORM   38.5(a) 
   IRISH  TAKEOVER   PANEL 
   DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH  TAKEOVER   PANEL ACT,  1997,  TAKEOVER  RULES, 2013 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A

CLIENT-SERVING   CAPACITY 
   1.       KEY   INFORMATION 
 
Name of exempt principal    J.P. Morgan Securities 
 trader                      Plc 
Company dealt in            Allergan plc 
                            ====================== 
Class of relevant security  Ordinary Share 
 to which the dealings 
 being disclosed relate 
 (Note 1) 
                            ====================== 
Date of dealing             6 May 2020 
                            ====================== 
 
   2.        DEALINGS  (Note   2) 
   (a)      Purchases and sales 
 
     Total number             Highest price paid     Lowest price 
      of relevant                  (Note 3)              paid 
  securities acquired                                  (Note 3) 
          -                        -                     - 
                       =========================  =============== 
 
 
  Total number          Highest price received     Lowest price 
  of securities                (Note 3)              received 
    disposed                                         (Note 3) 
      656                193.8900 USD            193.8900 USD 
                 =============================  =============== 
 
   (b)      Derivatives transactions (other than options transactions) 
 
  Product     Nature of transaction   Number of relevant   Price per 
    name,            (Note 4)             securities          unit 
  e.g. CFD                                 (Note 5)         (Note 3) 
Equity Swap 
             ======================  ===================  ========== 
 

Ap25

   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing,   selling, purchasing or varying 
 
  Product       Writing,      Number of      Exercise        Type,       Expiry          Option 
    name,       selling,      securities       price     e.g. American,   date     money paid/received 
  e.g. call    purchasing,     to which                     European                    per unit 
   option        varying      the option                      etc.                      (Note 3) 
                  etc.       relates (Note 
                                  5) 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     3) 
 
 
   3.      OTHER  INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option

referred   to   on   this   form   or 
   relating   to   the   voting   rights  or future acquisition or disposal of any relevant 

securities to which any derivative referred to on this form is referenced. If none, this

should   be   stated. 
 
Date of disclosure           8 May 2020 
Contact name                 Alwyn Basch 
                             ============================= 
Telephone number             020 7742 7407 
                             ============================= 
Name of offeree/offeror      Allergan plc 
 with which connected 
                             ============================= 
Nature of connection (Note   Financial Advisor to Allergan 
 6)                           plc 
                             ============================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISEBGGDUDXGDGGI

(END) Dow Jones Newswires

May 11, 2020 02:00 ET (06:00 GMT)

Grafico Azioni Allergan (LSE:0Y7T)
Storico
Da Dic 2024 a Gen 2025

Grafico Azioni Allergan (LSE:0Y7T)
Storico
Da Gen 2024 a Gen 2025